Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Analyst sentiment remains positive: Intuitive Surgical has a consensus “Moderate Buy” rating from 31 analysts, including 22 buys, eight holds and one sell. The average 12-month price target is approximately $508.68.
• The company’s latest quarterly results exceeded expectations, with EPS of $2.80 versus a $2.48 estimate and revenue of $2.89 billion, up 18.4% year over year. Shares opened at $373.57, well below their 52-week high of $603.88.
• Insiders sold roughly $7.0 million of stock over the past 90 days, while institutional investors and hedge funds own 83.64% of the company.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) has earned a consensus rating of "Moderate Buy" from the thirty-one analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and twenty-two have issued a buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $508.6830.

Several brokerages have recently issued reports on ISRG. Oppenheimer raised shares of Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price objective for the company in a research note on Wednesday, August 12th. BTIG Research cut their target price on Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating on the stock in a research report on Friday, July 17th. Piper Sandler reiterated an "overweight" rating on shares of Intuitive Surgical in a report on Friday. HSBC downgraded Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. Finally, Wall Street Zen lowered Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Saturday, August 15th.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $373.57 on Tuesday. The firm's 50-day simple moving average is $387.61 and its 200-day simple moving average is $435.53. Intuitive Surgical has a 1-year low of $328.57 and a 1-year high of $603.88. The firm has a market cap of $131.97 billion, a P/E ratio of 42.79, a PEG ratio of 2.74 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the previous year, the firm earned $1.81 earnings per share. Intuitive Surgical's revenue was up 18.4% compared to the same quarter last year. Analysts expect that Intuitive Surgical will post 8.87 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company's stock, valued at $498,271,600. The trade was a 0.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company's stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 17,283 shares of company stock worth $7,015,429. Company insiders own 0.60% of the company's stock.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in ISRG. Deutsche Bank AG raised its holdings in shares of Intuitive Surgical by 9.6% during the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider's stock valued at $862,108,000 after buying an additional 132,966 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its position in shares of Intuitive Surgical by 29.3% during the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider's stock worth $40,255,000 after buying an additional 16,119 shares during the period. Jag Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter worth approximately $18,771,000. Plato Investment Management Ltd bought a new position in Intuitive Surgical in the 2nd quarter worth approximately $4,315,000. Finally, Sycomore Asset Management acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $10,730,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source